Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Philip Gregory"'
Autor:
Nimrod Carmon, Alexander Berk, Niklas Bohn, Philip Gregory Brodrick, Olga Kalashnikova, Hai Nguyen, David Ray Thompson, Michael Turmon
Publikováno v:
Frontiers in Remote Sensing, Vol 3 (2022)
Models linking surface characteristics within incident solar radiation are inexorably dependent on the topography of the given region. To date, however, most operational surface reflectance retrievals treat this dependence by assuming a flat terrain,
Externí odkaz:
https://doaj.org/article/1aa3596b916d40f6b0dbca1619433f3b
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Media guidelines on suicide reporting of suicide have two purposes: to prevent further suicides, and to minimise distress to the bereaved, who are themselves at increased risk of suicide. We aimed to describe the subjective experi
Externí odkaz:
https://doaj.org/article/dfca2ee683e344ed992cd62dc0c8fc44
Autor:
Nur Diana Anuar, Sebastian Kurscheid, Matt Field, Lei Zhang, Edward Rebar, Philip Gregory, Thierry Buchou, Josephine Bowles, Peter Koopman, David J. Tremethick, Tatiana A. Soboleva
Publikováno v:
Genome Biology, Vol 20, Iss 1, Pp 1-16 (2019)
Abstract Background Altering the biochemical makeup of chromatin by the incorporation of histone variants during development represents a key mechanism in regulating gene expression. The histone variant H2A.B, H2A.B.3 in mice, appeared late in evolut
Externí odkaz:
https://doaj.org/article/1ac2215f698d4f058171c99f12cd4416
Autor:
Gretchen Lewis, Lauryn Christiansen, Jessica McKenzie, Min Luo, Eli Pasackow, Yegor Smurnyy, Sean Harrington, Philip Gregory, Gabor Veres, Olivier Negre, Melissa Bonner
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 9, Iss , Pp 313-322 (2018)
Lentiviral vector (LVV)-mediated transduction of human CD34+ hematopoietic stem and progenitor cells (HSPCs) holds tremendous promise for the treatment of monogenic hematological diseases. This approach requires the generation of a sufficient proport
Externí odkaz:
https://doaj.org/article/67f0223fe78441699cfcbacd86785e3a
Autor:
Kent, Philip Gregory
Publikováno v:
Collection Building, 2017, Vol. 36, Issue 4, pp. 137-142.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/CB-05-2017-0023
Autor:
Jeff Dozier, Edward H. Bair, Latha Baskaran, Philip Gregory Brodrick, Nimrod Carmon, Charles E. Miller, Kimberley Miner, Thomas H. Painter, David Ray Thompson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c09b7b8262ac382b94ddb68b1a89e994
https://doi.org/10.1002/essoar.10511568.3
https://doi.org/10.1002/essoar.10511568.3
Autor:
Philip Gregory, Beatriz Mateo-Victoriano, Ling Zhang, Cassie Due, Marijo Bilusic, Priyamvada Rai
Publikováno v:
Cancer Research. 83:4335-4335
Prostate cancer is the second most common cause of cancer-related deaths in American men. About 20-40% of patients with localized castration-sensitive prostate cancer (CSPC) eventually progress, requiring androgen deprivation therapy (ADT). However A
Autor:
Marijo Bilusic, NIcole J Toney, Renee Nicole Donahue, Fatima Karzai, Ravi Amrit Madan, Jeffrey Schlom, James L. Gulley, Priyamvada Rai, Cassie Due, Philip Gregory, Beatriz Mateo-Victoriano, Elizabeth R. Plimack, Daniel M. Geynisman
Publikováno v:
Journal of Clinical Oncology. 41:377-377
377 Background: Metformin impacts immune response in several ways. It protects CD8 TILs from apoptotic death, downregulates CD39 and CD73, reduces MDSC activity and suppresses the transcription of PD1 thus enhancing CD8+ T cell antitumor activity (Ma
Autor:
Michael Certo, Christopher Baldeviano, Sharlene Adams, Martin Asimis, Alexander Astrakhan, Andy Chavkin, Maria L. Cabral, Jimmy Chu, Marie Debrue, Devina Desai, John Evans, Pinky Htun, Amanda Iniguez, Jordan Jarjour, Carl Johnson, Harini Kantamneni, Sema Kurtulus, Michael Magee, Unja Martin, Seamus McKenney, Sara Miller, Prashant Nambiar, Vinh Khang Nguyen, Mauris Nnamani, Jen Obrigewitch, Lisa Pechilis, Molly Perkins, Christopher Petersen, Jason Pinger, Cindy Rogers, Nick Rouillard, Kendal Sanson, Emily Thompson, Collin Walter, Roslyn Yi, Sarah Voytek, Philip Gregory
Publikováno v:
Cancer Research. 82:581-581
Anti-CD19 CAR T cell therapies have improved outcomes for non-Hodgkin lymphoma (NHL) patients. However, only 30-40% of patients treated with commercially available CART cell therapies obtain long term remission, highlighting the need for more efficac